3D Guided Internal Jugular Vein Catheterization (3D Givenchy)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04683302 |
|
Recruitment Status :
Completed
First Posted : December 24, 2020
Last Update Posted : October 5, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Catheter Related Complication Ultrasound; Complications | Device: 3DUS biplanar catheterization Device: 2D US catheterization | Not Applicable |
Central venous catheters (CVC) are frequently placed in patients who are scheduled for cardiothoracic surgery (ICU). Ultrasound (US) guidance has consistently shown to not only improve success rate of procedures, but also to decrease complications with most benefit for the jugular vein. However, serious adverse events still occur despite US guidance Conventional two dimensional ultrasound (2D US) guided access if performed in either the short axis or long axis view, with both approaches having their own limitations. Using short axis view, the operator is never certain of the position of the needle tip as the shaft of the needle is not distinguishable from the tip in this view. Structures not (yet) visible in the US screen can already be punctured, or a vessel can be entered at a different position than preferred. A possible mechanism through which carotid artery puncture can happen is the posterior wall puncture4.
For long axis view, with proper technique the needle is viewed entirely during the procedure. However, this requires extensive experience and the overview of surrounding structures is lost.Multiple attempts at improving US guided venous access have been tried, such as oblique visualization or alternating short and long axis views but those approaches still have their shortcomings.
Three dimensional ultrasound (3D US) has a theoretical advantage of increased anatomical awareness, but evidence of improvement in needle based procedures is scarce.
Recently, a new 3D US probe is introduced which can address the above mentioned limitations of 2D US for access procedures.
The investigators hypothesize that this superior three dimensional awareness can improve needle placement during central venous catheterization, increasing success rates and potentially decreasing complications.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 126 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | randomized clinical trial (RCT) |
| Masking: | Double (Participant, Outcomes Assessor) |
| Masking Description: | coded (e)crf's and anonymized and coded ultrasound clips |
| Primary Purpose: | Prevention |
| Official Title: | 3D Biplane vs Conventional 2D Ultrasound Guided Internal Jugular VEin caNnulation in CardiotHoracic surgerY Patients |
| Actual Study Start Date : | March 15, 2021 |
| Actual Primary Completion Date : | August 15, 2021 |
| Actual Study Completion Date : | September 15, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: control
conventional 2D guided internal jugular vein catheterization
|
Device: 2D US catheterization
2D short axis internal jugular vein catheterization |
|
Experimental: intervention
3D biplanar guided internal jugular vein catheterization
|
Device: 3DUS biplanar catheterization
biplanar view of both short and long axis view of the internal jugular vein improves anatomical awareness and potentially improves safety of venous catheterization |
- first pass success [ Time Frame: during procedure/surgery ]successful entry in internal jugular vein within one skin break and fluid motion
- imaging time [ Time Frame: during procedure/surgery ]time from placing USprobe until start needling (in seconds)
- needling time [ Time Frame: during procedure/surgery ]time from puncturing skin until access in vein (in seconds)
- number of skin punctures [ Time Frame: during procedure/surgery ]total skin breaks needed before successful entry in vein
- number of needle withdrawals [ Time Frame: during procedure/surgery ]redirections of needle >5mm without needing new skin breaks
- number of posterior wall punctures [ Time Frame: during procedure/surgery ]puncture of posterior wall of jugular vein
- operator satisfaction [ Time Frame: procedure/surgery ]satisfaction of operator with visual feedback from US, rated on Likert Scale 1-5 with 1 no satisfaction at all and 5 totally satisfied
- needle visibility [ Time Frame: procedure/surgery ]visualization of needle during procedure on US screen, rating from good - adequate - poor
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- elective cardiothoracic surgery with need for central venous catheter placement
- written informed consent
Exclusion Criteria:
- no informed consent
- other site for central line placement (eg subclavian vein)
- emergency surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04683302
| Netherlands | |
| Catharina Ziekenhuis Eindhoven | |
| Eindhoven, Noord-Brabant, Netherlands, 5623 EJ | |
| Responsible Party: | Harm Scholten, MD, Catharina Ziekenhuis Eindhoven |
| ClinicalTrials.gov Identifier: | NCT04683302 |
| Other Study ID Numbers: |
3DJUG |
| First Posted: | December 24, 2020 Key Record Dates |
| Last Update Posted: | October 5, 2021 |
| Last Verified: | October 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
ultrasound internal jugular vein cardiothoracic surgery |

